IGF2BP3 is overexpressed in the MLL translocated subtype of B- ALL, and IGF2BP1 is seen to be overexpressed in the ETV6-RUNX1 subtype of B-ALL (259, 260). Here, RUNX1 is linked to acute lymphoblastic leukemia.